Health

Sugar Intake During Antibiotic Treatment May Worsen Gut Microbiome Disruption

Consuming sweets and simple sugars during antibiotic treatment was associated with greater gut microbiome disruption, including reduced microbial diversity and expansion of the pathobiont Enterococcus. In this study, researchers precisely tracked 9,419 meals consumed by 173 patients undergoing haematopoietic cell transplantation and analyzed longitudinal microbiome changes in 158 patients with paired samples. Bayesian analyses showed that higher intake of sweets and sugars during antibiotic exposure predicted more severe dysbiosis, characterized by lower α-diversity and greater Enterococcus expansion. Experiments in mice further demonstrated that sucrose supplementation increased and prolonged antibiotic-induced Enterococcus expansion. These findings suggest that limiting foods rich in simple sugars during antibiotic treatment may help reduce microbiome disruption. Source: https://www.nature.com/

hyangiu

Recent Posts

ACS Updates Prostate Cancer Screening Guidance

The American Cancer Society (ACS) concludes that the benefits of PSA-based screening for prostate cancer…

22 hours ago

Proton Pump Inhibitor Use Linked to Dementia Risk in Older Adults

Proton pump inhibitor (PPI) use was modestly associated with incident dementia in older adults (pooled…

2 days ago

Long-Term Outcomes of Invasive vs Conservative Management in Stable Coronary Disease: Consistent Evidence From Extended Follow-Up Trials

Extended follow-up of three major trials consistently shows that an initial invasive strategy does not…

3 days ago

Antidepressants Differ in Efficacy and Acceptability in Long-Term Treatment of Major Depressive Disorder

Escitalopram, duloxetine, and agomelatine achieved higher sustained response rates than fluoxetine, while escitalopram and duloxetine…

3 days ago

Intensive BP Control Reduces Cardiovascular Events After Ischemic Stroke

Targeting a systolic blood pressure (BP) of less than 120 mm Hg lowered the incidence…

6 days ago

No Significant Reduction in Major Cardiovascular Events with Intensive BP Lowering in T2D

In patients with type 2 diabetes (T2D) and high cardiovascular risk, targeting a systolic blood…

6 days ago

This website uses cookies.